Industry Briefs: May 7, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Almac has installed an Uhlmann high-speed blister line in its new US commercial packaging facility.
Celsion has signed a long-term commercial-supply agreement with Zhejiang Hisun Pharmaceutical for the production of ThermoDox, a heat-activated liposomal encapsulation of doxorubicin.
Evotec has signed a compound-management agreement with the US Environmental Protection Agency. The contract covers a period of five years and has a total value of up to EUR 7.7 million ($10 million).
Grain Processing Corporation (GPC) has opened its new
Lorus Therapeutics and Genentech have signed a global intellectual property license agreement for IL-17E, a drug for treating cancer.
Marina Biotech has announced a worldwide exclusive licensing agreement with Monsanto for Marina Biotech’s delivery and chemistry technologies.
Pii has provided funding for hot-melt extrusion capabilities at the University of Mississippi.
Sartorius Stedim Biotech and c-LEcta have signed a sales and distribution agreement for c-LEcta’s proprietary Serratia marcescens nuclease for biopharmaceutical applications.
SGS Life Science Services has announced the availability of preformulation and formulation services at its laboratory in Lincolnshire, Illinois.
People News
Althea Technologies has appointed Kristin DeFife as director of biologics manufacturing and Jack Wright as vice-president of sales and marketing.
Covance has announced several executive appointments.
EMD Millipore has appointed Andrew Bulpin as head of the company’s process solutions business unit.
GlaxoSmithKline named James Shannon chief medical officer, effective May 1, 2012.
In other news, GlaxoSmithKline has appointed Lynn Elsenhans and Jing Ulrich to its board as nonexecutive directors, effective July 1, 2012.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
